Lupin's OTC Plans Come into Focus: LUPINLIFE Consumer Healthcare Incorporated

Lupin Limited has successfully incorporated its wholly-owned subsidiary, LUPINLIFE Consumer Healthcare Limited. This strategic initiative, initially approved by Lupin's board on February 11, 2025, is a major milestone in the company's strategy to maximize its over-the-counter (OTC) consumer healthcare business.

 

Highlights:

 

1)LUPINLIFE Consumer Healthcare Limited incorporated on March 18, 2025

 

2)New company to concentrate on OTC drug and consumer healthcare products trading and manufacturing

 

3)Part of Lupin's overall plan to demerge its OTC business through a slump sale worth ₹550-650 crore

 

4)Deal expected to be completed by June 30, 2025, subject to regulatory approvals

 

This expansion supports Lupin's strategy to expand its consumer healthcare emphasis and drive growth in the OTC business. The new subsidiary will function autonomously while being fully owned by Lupin Limited, which will enable more focused strategies in the aggressive OTC marketplace.

 

Sources: Moneycontrol, Lupin Limited Regulatory Filings, March 18, 2025